752 related articles for article (PubMed ID: 21068237)
1. A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry.
Shulla A; Heald-Sargent T; Subramanya G; Zhao J; Perlman S; Gallagher T
J Virol; 2011 Jan; 85(2):873-82. PubMed ID: 21068237
[TBL] [Abstract][Full Text] [Related]
2. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein.
Heurich A; Hofmann-Winkler H; Gierer S; Liepold T; Jahn O; Pöhlmann S
J Virol; 2014 Jan; 88(2):1293-307. PubMed ID: 24227843
[TBL] [Abstract][Full Text] [Related]
3. Bat SARS-Like WIV1 coronavirus uses the ACE2 of multiple animal species as receptor and evades IFITM3 restriction
Zheng M; Zhao X; Zheng S; Chen D; Du P; Li X; Jiang D; Guo JT; Zeng H; Lin H
Emerg Microbes Infect; 2020 Dec; 9(1):1567-1579. PubMed ID: 32602823
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Hoffmann M; Kleine-Weber H; Schroeder S; Krüger N; Herrler T; Erichsen S; Schiergens TS; Herrler G; Wu NH; Nitsche A; Müller MA; Drosten C; Pöhlmann S
Cell; 2020 Apr; 181(2):271-280.e8. PubMed ID: 32142651
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation.
Hörnich BF; Großkopf AK; Schlagowski S; Tenbusch M; Kleine-Weber H; Neipel F; Stahl-Hennig C; Hahn AS
J Virol; 2021 Apr; 95(9):. PubMed ID: 33608407
[TBL] [Abstract][Full Text] [Related]
6. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.
Matsuyama S; Nagata N; Shirato K; Kawase M; Takeda M; Taguchi F
J Virol; 2010 Dec; 84(24):12658-64. PubMed ID: 20926566
[TBL] [Abstract][Full Text] [Related]
7. ACE2 acts as a novel regulator of TMPRSS2-catalyzed proteolytic activation of influenza A virus in airway cells.
Heindl MR; Rupp A-L; Schwerdtner M; Bestle D; Harbig A; De Rocher A; Schmacke LC; Staker B; Steinmetzer T; Stein DA; Moulton HM; Böttcher-Friebertshäuser E
J Virol; 2024 Apr; 98(4):e0010224. PubMed ID: 38470058
[TBL] [Abstract][Full Text] [Related]
8. Evidence for ACE2-utilizing coronaviruses (CoVs) related to severe acute respiratory syndrome CoV in bats.
Demogines A; Farzan M; Sawyer SL
J Virol; 2012 Jun; 86(11):6350-3. PubMed ID: 22438550
[TBL] [Abstract][Full Text] [Related]
9. Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease.
Bertram S; Glowacka I; Müller MA; Lavender H; Gnirss K; Nehlmeier I; Niemeyer D; He Y; Simmons G; Drosten C; Soilleux EJ; Jahn O; Steffen I; Pöhlmann S
J Virol; 2011 Dec; 85(24):13363-72. PubMed ID: 21994442
[TBL] [Abstract][Full Text] [Related]
10. Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin.
Ren W; Qu X; Li W; Han Z; Yu M; Zhou P; Zhang SY; Wang LF; Deng H; Shi Z
J Virol; 2008 Feb; 82(4):1899-907. PubMed ID: 18077725
[TBL] [Abstract][Full Text] [Related]
11. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme 2 (ACE2) from raccoon dog can serve as an efficient receptor for the spike protein of severe acute respiratory syndrome coronavirus.
Xu L; Zhang Y; Liu Y; Chen Z; Deng H; Ma Z; Wang H; Hu Z; Deng F
J Gen Virol; 2009 Nov; 90(Pt 11):2695-2703. PubMed ID: 19625462
[TBL] [Abstract][Full Text] [Related]
13. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
Li K; Meyerholz DK; Bartlett JA; McCray PB
mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
[TBL] [Abstract][Full Text] [Related]
14. Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research.
Simmons G; Zmora P; Gierer S; Heurich A; Pöhlmann S
Antiviral Res; 2013 Dec; 100(3):605-14. PubMed ID: 24121034
[TBL] [Abstract][Full Text] [Related]
15. Cell entry mechanisms of SARS-CoV-2.
Shang J; Wan Y; Luo C; Ye G; Geng Q; Auerbach A; Li F
Proc Natl Acad Sci U S A; 2020 May; 117(21):11727-11734. PubMed ID: 32376634
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry.
Hou Y; Peng C; Yu M; Li Y; Han Z; Li F; Wang LF; Shi Z
Arch Virol; 2010 Oct; 155(10):1563-9. PubMed ID: 20567988
[TBL] [Abstract][Full Text] [Related]
17. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.
Zhao X; Chen D; Szabla R; Zheng M; Li G; Du P; Zheng S; Li X; Song C; Li R; Guo JT; Junop M; Zeng H; Lin H
J Virol; 2020 Aug; 94(18):. PubMed ID: 32661139
[TBL] [Abstract][Full Text] [Related]
18. Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts.
Bertram S; Heurich A; Lavender H; Gierer S; Danisch S; Perin P; Lucas JM; Nelson PS; Pöhlmann S; Soilleux EJ
PLoS One; 2012; 7(4):e35876. PubMed ID: 22558251
[TBL] [Abstract][Full Text] [Related]
19. Host Cell and SARS-CoV-2-Associated Molecular Structures and Factors as Potential Therapeutic Targets.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Roshan R; Azam F; Mehta J; Handu S; Prasad R; Jain N; Pandey AK; Dhamija P
Cells; 2021 Sep; 10(9):. PubMed ID: 34572076
[TBL] [Abstract][Full Text] [Related]
20. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia.
Jia HP; Look DC; Shi L; Hickey M; Pewe L; Netland J; Farzan M; Wohlford-Lenane C; Perlman S; McCray PB
J Virol; 2005 Dec; 79(23):14614-21. PubMed ID: 16282461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
